Shan Jing

5PUBLICATIONS
2CO-AUTHORS
PharmacogenomicsToxicology (incl. clinical toxicology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|May 20, 2026
Safety, tolerability, pharmacokinetics, pharmacodynamics and food effect of HRS-1893, a cardiac myosin inhibitor, in healthy subjects.

|Apr 19, 2025
Pharmacokinetics and Pharmacodynamics of Prusogliptin (DBPR108), a Once-Daily Dipeptidyl Peptidase-4 Inhibitor, in Patients with Type 2 Diabetes.

Wenfang Liu, Kexu Yang, Yang Lin

|Nov 19, 2023
Pharmacokinetics and Safety of the Tyrosine Kinase 2 Inhibitor Deucravacitinib in Healthy Chinese Subjects.

Shan Jing, Yang Lin, Randy Dockens

|Feb 06, 2023
A Single- and Multiple-Dose Pharmacokinetic Study of Oral Perampanel in Healthy Chinese Subjects.

Shan Jing, Sari Shiba, Masafumi Morita

|Dec 10, 2022
The randomized, single- and multiple- ascending dose studies of the safety, tolerability, pharmacokinetics of CSPCHA115 in healthy Chinese subjects.

Shan Jing, Wenfang Liu, Kexu Yang

Pageof 1

Frequent Collaborators

2 joint publications

Yang Lin

1 joint publications

Meng Fu